Literature DB >> 3954599

Complement activation by respiratory syncytial virus-infected cells.

K M Edwards, P N Snyder, P F Wright.   

Abstract

Respiratory syncytial virus (RSV), a major respiratory pathogen of children, has been speculated to cause disease by immunologic mechanisms. Although circulating levels of complement (C) are normal during RSV infections, the role of C in respiratory tract secretion is unclear. Since epithelial cells of the respiratory tract of children infected with RSV express viral surface antigens, the ability of RSV infected human cells to activate C was studied. RSV infected human cells (HeLa) were found to activate both the classical and alternative C pathways as measured by the cleavage of native C3 into its breakdown products. Increased C activation occurred in the presence of antibody. Cytolysis of RSV infected cells was then studied using a chromium release assay. Both the classical and alternative C pathways in the presence of antibody participated in the lysis of RSV infected cells. The combined effects of activation of C and the lysis of RSV infected cells by C and antibody may contribute to the pathogenesis of disease.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3954599     DOI: 10.1007/bf01310889

Source DB:  PubMed          Journal:  Arch Virol        ISSN: 0304-8608            Impact factor:   2.574


  16 in total

1.  Activation of the alternative pathway of guinea pig complement by Sendai virus-treated cells.

Authors:  N Okada; H Shibuta; H Okada
Journal:  Microbiol Immunol       Date:  1979       Impact factor: 1.955

2.  Influence of immunological factors in respiratory syncytial virus disease.

Authors:  R M Chanock; A Z Kapikian; J Mills; H W Kim; R H Parrott
Journal:  Arch Environ Health       Date:  1970-09

3.  An epidemiologic study of altered clinical reactivity to respiratory syncytial (RS) virus infection in children previously vaccinated with an inactivated RS virus vaccine.

Authors:  A Z Kapikian; R H Mitchell; R M Chanock; R A Shvedoff; C E Stewart
Journal:  Am J Epidemiol       Date:  1969-04       Impact factor: 4.897

4.  Serum complement in acute bronchiolitis.

Authors:  P P Ana; J O Arrobio; H W Kim; C D Brandt; R M Chanock; R H Parrott
Journal:  Proc Soc Exp Biol Med       Date:  1970-06

Review 5.  Immunopathologic mechanisms in lower respiratory tract disease of infants due to respiratory syncytial virus.

Authors:  K McIntosh; J M Fishaut
Journal:  Prog Med Virol       Date:  1980

6.  The role of complement in viral infections. III. Activation of the classical and alternative complement pathways by Sindbis virus.

Authors:  R L Hirsch; J A Winkelstein; D E Griffin
Journal:  J Immunol       Date:  1980-05       Impact factor: 5.422

7.  Inflammatory and immune processes in the human lung in health and disease: evaluation by bronchoalveolar lavage.

Authors:  G W Hunninghake; J E Gadek; O Kawanami; V J Ferrans; R G Crystal
Journal:  Am J Pathol       Date:  1979-10       Impact factor: 4.307

8.  Antibody-dependent cell-mediated cytotoxicity against cells infected with respiratory syncytial virus: characterization of in vitro and in vivo properties.

Authors:  H Meguro; M Kervina; P F Wright
Journal:  J Immunol       Date:  1979-06       Impact factor: 5.422

9.  Development of antibody-dependent cell-mediated cytotoxicity in the respiratory tract after natural infection with respiratory syncytial virus.

Authors:  T N Kaul; R C Welliver; P L Ogra
Journal:  Infect Immun       Date:  1982-08       Impact factor: 3.441

10.  Virus-induced complement activation and neutrophil-mediated cytotoxicity against respiratory syncytial virus (RSV).

Authors:  T N Kaul; H Faden; R Baker; P L Ogra
Journal:  Clin Exp Immunol       Date:  1984-06       Impact factor: 4.330

View more
  5 in total

Review 1.  The respiratory syncitial virus and its role in acute bronchiolitis.

Authors:  M L Everard; A D Milner
Journal:  Eur J Pediatr       Date:  1992-09       Impact factor: 3.183

2.  Attachment of human polymorphonuclear leukocytes to herpes simplex virus-infected fibroblasts mediated by antibody-independent complement activation.

Authors:  J A van Strijp; K P van Kessel; L A Miltenburg; A C Fluit; J Verhoef
Journal:  J Virol       Date:  1988-03       Impact factor: 5.103

3.  Analysis of cells obtained by bronchial lavage of infants with respiratory syncytial virus infection.

Authors:  M L Everard; A Swarbrick; M Wrightham; J McIntyre; C Dunkley; P D James; H F Sewell; A D Milner
Journal:  Arch Dis Child       Date:  1994-11       Impact factor: 3.791

Review 4.  In the Crosshairs: RNA Viruses OR Complement?

Authors:  Nisha Asok Kumar; Umerali Kunnakkadan; Sabu Thomas; John Bernet Johnson
Journal:  Front Immunol       Date:  2020-09-29       Impact factor: 7.561

5.  Species-specific transcriptomic changes upon respiratory syncytial virus infection in cotton rats.

Authors:  Britton A Strickland; Seesandra V Rajagopala; Arash Kamali; Meghan H Shilts; Suman B Pakala; Marina S Boukhvalova; Shibu Yooseph; Jorge C G Blanco; Suman R Das
Journal:  Sci Rep       Date:  2022-10-04       Impact factor: 4.996

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.